Provided by Tiger Trade Technology Pte. Ltd.

Myriad Genetics

3.22
+0.06001.90%
Pre-market: 2.99-0.2300-7.14%05:53 EDT
Volume:1.54M
Turnover:4.92M
Market Cap:307.83M
PE:-2.68
High:3.26
Open:3.15
Low:3.04
Close:3.16
52wk High:8.59
52wk Low:2.74
Shares:95.60M
Float Shares:79.40M
Volume Ratio:1.09
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2031
EPS(LYR):-3.9514
ROE:-32.54%
ROA:-8.59%
PB:1.01
PE(LYR):-0.81

Loading ...

Myriad Genetics launches Prolaris + AI prostate cancer test combining genomics, digital pathology AI

Reuters
·
May 27

Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

THOMSON REUTERS
·
May 27

MindWalk Holdings Leads Our Trio Of Promising Penny Stocks

Simply Wall St.
·
May 23

Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life

GlobeNewswire
·
May 15

Myriad Genetics Director Paul Bisaro acquires 7,500 shares for $27,637.50

Reuters
·
May 15

Myriad Genetics to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 08

Myriad Genetics price target lowered to $6 from $7 at TD Cowen

TIPRANKS
·
May 07

Myriad Genetics Bets on Growth Amid Profit Squeeze

TIPRANKS
·
May 07

Myriad Genetics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 06

Piper Sandler Reaffirms Their Buy Rating on Myriad Genetics (MYGN)

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

TIPRANKS
·
May 06

Myriad Genetics Q1 revenue growth misses estimates

Reuters
·
May 06

Myriad Genetics Q1 Adj. EPS $(0.09) Misses $(0.07) Estimate, Sales $200.400M Miss $202.484M Estimate

Benzinga Earnings
·
May 06

BRIEF-Myriad Genetics Q1 EPS USD -0.36

Reuters
·
May 06

Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business

GlobeNewswire
·
May 06

Myriad Genetics Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
May 02

Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan

GlobeNewswire
·
Apr 30

Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026

GlobeNewswire
·
Apr 29

Myriad reports new MONITOR-Breast trial results for Precise MRD at AACR 2026

Reuters
·
Apr 16